1)Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical syntax trial. Lancet. 2013; 381: 629-38
|
|
|
2)Farkouh ME, Domanski M, Sleeper LA, et al; FREEDOM Trial investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367: 2375-84
|
|
|
3)慢性心不全治療ガイドライン(2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/jcs2010 matsuzaki_h.pdf
|
|
|
4)Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (cass). Circulation. 1983; 68: 785-95
|
|
|
5)O’Connor CM, Velazquez EJ, Gardner LH, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the duke cardiovascular disease databank). Am J Cardiol. 2002; 90: 101-7
|
|
|
6)Velazquez EJ, Williams JB, Yow E, et al. Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg. 2012; 93: 523-30
|
|
|
7)Killip T. The national heart, lung, and blood institute coronary-artery surgery study (CASS) - a multi-center comparison of the effects of randomized medical and surgical-treatment of mildly symptomatic patients with coronary-artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation. 1981; 63: 1-81
|
|
|
8)Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation. 1990; 82: 1629-46
|
|
|
9)Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994; 344: 563-70
|
|
|
10)Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J med. 2009; 360: 1705-17
|
|
|
11)Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011; 364: 1617-25
|
|
|
12)Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011; 364: 1607-16
|
|
|
13)Wallace TW, Berger JS, Wang A, et al. Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. Am J Cardiol. 2009; 103: 355-60
|
|
|
14)Tsuyuki RT, Shrive FM, Galbraith PD, et al. Revascularization in patients with heart failure. CMAJ. 2006; 175: 361-5
|
|
|
15)Kunadian V, Pugh A, Zaman AG, et al. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: A review and meta-analysis of 19 clinical studies. Coron Artery Dis. 2012; 23: 469-79
|
|
|
16)Windecker S, Kolh P, Alfonso F, et al; Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014; 35: 2541-619
|
|
|
17)Fihn SD, Gardin JM, Abrams J, et al; American College of Cardiology Foundation. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126: 3097-137
|
|
|
18)Berger PB, Velianou JL, Aslanidou Vlachos H, et al; BARI Investigators. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2001; 38: 1440-9
|
|
|
19)Morrison DA, Sethi G, Sacks J, et al. A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs. Control Clin Trials. 1999; 20: 601-19
|
|
|
20)Sedlis SP, Ramanathan KB, Morrison DA, et al. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). Am J Cardiol. 2004; 94: 118-20
|
|
|
21)Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. Coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008; 358: 331-41
|
|
|
22)Nagendran J, Norris CM, Graham MM, et al. Coronary revascularization for patients with severe left ventricular dysfunction. Ann Thorac Surg. 2013; 96: 2038-44
|
|
|
23)Hlatky MA, Boothroyd DB, Baker L, et al. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention a cohort study. Ann Intern Med. 2013; 158: 727-34
|
|
|
24)Hlatky M, Boothroyd D, Bravata D, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009; 373: 1190-7
|
|
|
25)虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン(2011年改訂版).http://www.j-circ.or.jp/guideline/pdf/jcs2011_ochi_h.pdf
|
|
|
26)安定冠動脈疾患における待機的pciのガイドライン(2011年改訂版).http://www.j-circ.or.Jp/guideline/pdf/jcs2011_fujiwara_h.pdf
|
|
|
27)Eagle KA, Guyton RA, Davidoff R, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Society for Thoracic Surgery and the Society of Thoracic Surgeons. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004; 110: 1168-76
|
|
|
28)McMurray JJ, Adamopoulos S, Anker SD, et al; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33: 1787-847
|
|
|
29)WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, Bozkurt B, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128: e240-327
|
|
|
30)Fihn SD, Gardin JM, Abrams J; American College of Cardiology Foundation/American Heart Association Task Force. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012; 126: e354-471
|
|
|
31)Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011; 124: e574-651
|
|
|
32)Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 124: e652-735
|
|
|
33)Marui A, Kimura T, Nishiwaki N, et al; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions ≦ 50% versus >50% (from the credo-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014; 114: 988-96
|
|
|
34)Kimura T, Morimoto T, Furukawa Y, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation. 2008; 118: S199-209
|
|
|
35)Kimura T, Morimoto T, Furukawa Y, et al. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther. 2011; 26: 234-45
|
|
|
36)O’Keefe JH Jr, Allan JJ, McCallister BD, et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%. Am J Cardiol. 1993; 71: 897-901
|
|
|
37)Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004; 109: 2290-5
|
|
|
38)Gioia G, Matthai W, Gillin K, et al. Revascularization in severe left ventricular dysfunction: Outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheter Cardiovasc Interv. 2007; 70: 26-33
|
|
|
39)Yang JH, Choi SH, Song YB, et al. Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction. Am J Cardiol. 2013; 112: 623-9
|
|
|
40)Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol. 2002; 39: 1151-8
|
|
|
41)Di Donato M, Castelvecchio S, Menicanti L. End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy. Euro J Heart Fail. 2010; 12: 375-81
|
|
|
42)Oh JK, Velazquez EJ, Menicanti L, et al. Influence of baseline left ventricular function on theclinical outcome of surgical ventricular reconstruction in patients with ischaemic cardio-myopathy. Eur Heart J. 2013; 34: 39-47
|
|
|
43)Michler RE, Rouleau JL, Al-Khalidi HR, et al; STICH Trial investigators. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013; 146: 1139-45 e1136
|
|
|
44)Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term cass experience. Circulation. 1995; 91: 2335-44
|
|
|
45)VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the veterans affairs cooperative study of coronary artery bypass surgery for stable angina. Circulation. 1992; 86: 121-30
|
|
|
46)Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984; 311: 1333-9
|
|
|
47)Cleland JG, Calvert M, Freemantle N, et al. The heart failure revascularisation trial (heart). Eur J Heart Fail. 2011; 13: 227-33
|
|
|
48)Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation. 2009; 119: 1330-52
|
|
|